Company
Bridgene Biosciences
Redefining drug discovery with covalent chemistry and proteome-wide insights.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
BridGene Biosciences is a biotechnology company focused on discovering and developing innovative small molecules to drug high-value yet previously undruggable targets, providing more paths to treat diseases.
Funding snapshot
- Total raised
- $28MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $28M2025-10-16
Funding rounds
- Series B
- $28M2025-10-16, Company stated
Loading relationship preview